Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Xylitol, a sugar alcohol commonly used as a sweetener, has garnered some scientific interest for its potential to support the body in fighting viral infections, particularly respiratory infections. The evidence comes primarily from in vitro (test tube) and animal studies. For instance, research in mice has shown that dietary xylitol can reduce the severity of influenza A virus infection, possibly by reducing viral load and inflammation (Kim et al., 2008). Xylitol is also known to help maintain nasal and oral moisture, and it is sometimes used in nasal sprays; a few small human studies suggest these sprays might reduce the risk of upper respiratory tract infections, potentially by interfering with viral adhesion to mucosal surfaces. However, robust clinical trials in humans are lacking, and the mechanisms by which xylitol could affect viral infections are not fully understood. While xylitol has a well-established role in oral health (e.g., reducing dental caries by inhibiting certain bacteria), its antiviral effects are still considered preliminary. Thus, while there is emerging scientific evidence suggesting a potential benefit, it is not yet strong or conclusive, and xylitol cannot be considered a proven or primary treatment for viral infections at this time. Further clinical research is needed to establish its effectiveness and practical applications in human viral illness.

More about xylitol
More about Infection (viral)

Other ingredients used for Infection (viral)

Other health conditions supported by xylitol

Products containing xylitol